1. In vitro evaluation of the effects of 4-aminopyridine on cytochrome P450 enzymes. (23rd April 2013) Authors: Caggiano, Anthony; Blight, Andrew Journal: Journal of drug assessment Issue: Volume 2(2013) Page Start: 106 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Identification of metabolites of dalfampridine (4-aminopyridine) in dog and rat. (23rd April 2013) Authors: Caggiano, Anthony; Blight, Andrew; Parry, Tom J. Journal: Journal of drug assessment Issue: Volume 2(2013) Page Start: 72 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effects of dalfampridine and its metabolites on cloned human potassium channels Kv 1.1, Kv 1.2, and Kv 1.4 expressed in human embryonic kidney cells. (23rd April 2013) Authors: Caggiano, Anthony; Blight, Andrew; Parry, Tom J. Journal: Journal of drug assessment Issue: Volume 2(2013) Page Start: 58 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Identification of metabolites of dalfampridine (4-aminopyridine) in human subjects and reaction phenotyping of relevant cytochrome P450 pathways. (23rd April 2013) Authors: Caggiano, Anthony; Blight, Andrew Journal: Journal of drug assessment Issue: Volume 2(2013) Page Start: 117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Identification of metabolites of dalfampridine (4-aminopyridine) in dog and rat. (21st June 2013) Authors: Caggiano, Anthony; Blight, Andrew; Parry, Tom J. Journal: Journal of drug assessment Issue: Volume 2(2013) Page Start: 72 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. In vitro evaluation of the effects of 4-aminopyridine on cytochrome P450 enzymes. (20th August 2013) Authors: Caggiano, Anthony; Blight, Andrew Journal: Journal of drug assessment Issue: Volume 2(2013) Page Start: 106 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Identification of metabolites of dalfampridine (4-aminopyridine) in human subjects and reaction phenotyping of relevant cytochrome P450 pathways. (29th August 2013) Authors: Caggiano, Anthony; Blight, Andrew Journal: Journal of drug assessment Issue: Volume 2(2013) Page Start: 117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The Spinal Cord Ability Ruler (SCAR) complements the Spinal Cord Independence Measure (SCIM). Issue 5 (May 2018) Authors: Steeves, John; Curt, Armin; Mehra, Munish; Rupp, Rüdiger; Blight, Andrew; Maier, Doris; Jones, Linda; Lammertse, Daniel; Abel, Rainer; Kirshblum, Steven; Weidner, Norbert Journal: Spinal cord Issue: Volume 56:Issue 5(2018:May) Page Start: 525 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Considerations and recommendations for selection and utilization of upper extremity clinical outcome assessments in human spinal cord injury trials. Issue 5 (May 2018) Authors: Jones, Linda; Bryden, Anne; Wheeler, Tracey; Tansey, Keith; Anderson, Kim; Beattie, Michael; Blight, Andrew; Curt, Armin; Field-Fote, Edelle; Guest, James; Hseih, Jane; Jakeman, Lyn; Kalsi-Ryan, Sukhvinder; Krisa, Laura; Lammertse, Daniel; Leiby, Benjamin; Marino, Ralph; Schwab, Jan; Scivoletto, ... Journal: Spinal cord Issue: Volume 56:Issue 5(2018:May) Page Start: 414 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Effects of dalfampridine and its metabolites on cloned human potassium channels Kv 1.1, Kv 1.2, and Kv 1.4 expressed in human embryonic kidney cells. (23rd April 2013) Authors: Caggiano, Anthony; Blight, Andrew; Parry, Tom J. Journal: Journal of drug assessment Issue: Volume 2(2013) Page Start: 58 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗